Drug class in one race
IL-12 p40 drugs for Crohn's Disease
8 tracked IL-12 p40 drugs in the Crohn's Disease race. The class explanation lives on the IL-12 p40 page; the full indication pipeline across every mechanism is on the Crohn's Disease page.
8 approved / phase 4
Head-to-head evidence: ustekinumab vs ustekinumab-aauz (Otulfi) · ustekinumab vs ustekinumab-aekn (Selarsdi) · ustekinumab vs ustekinumab-auub (Wezlana) · ustekinumab vs ustekinumab-hmny (Starjemza) · ustekinumab vs ustekinumab-srlf (Imuldosa) · ustekinumab vs ustekinumab-stba (Steqeyma)